Loss of CBP causes T cell lymphomagenesis in synergy with p27 Kip1 insufficiency

Ningling Kang-Decker, Caili Tong, Fayçal Boussouar, Darren J. Baker, Wu Xu, Alexey A. Leontovich, William R. Taylor, Paul K. Brindle, Jan M.A. Van Deursen

Research output: Contribution to journalArticlepeer-review

83 Scopus citations


CBP can function as a tumor suppressor, but the mechanisms that govern oncogenesis in its absence are unknown. Here we show that CBP inactivation in mouse thymocytes leads to lymphoma. Although CBP has been implicated in the transactivation functions of p53, development of these tumors does not seem to involve loss of p53 activity. CBP-null tumors show reduced levels of p27 Kip1 and increased levels of cyclin E and Skp2, two oncoproteins that can promote p27Kip1 proteolysis. Reduction of p27 Kip1 by introduction of a p27Kip1-null allele into CBP knockout mice accelerates lymphomagenesis and seems to obviate the requirement for Skp2 and cyclin E upregulation. These data suggest that CBP loss mediates lymphomagenesis in cooperation with a mechanism that reduces p27Kip1 abundance.

Original languageEnglish (US)
Pages (from-to)177-189
Number of pages13
JournalCancer Cell
Issue number2
StatePublished - Feb 2004

Bibliographical note

Funding Information:
We thank Peter Aplan for the TCR Cβ2 probe. We thank Rick Bram, Fergus Couch, David McKean, Junjie Chen, Larry Karnitz, Janine van Ree, and Ralf Janknecht for critically reviewing our manuscript, helpful discussions, or reagents. We are grateful to Karthik Jeganathan for help with various Western blot analyses. This work was supported by DOD IDEA AWARD BC010517, NIH grants R01-CA76385 and P30-CA21765, and the American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital.


Dive into the research topics of 'Loss of CBP causes T cell lymphomagenesis in synergy with p27 Kip1 insufficiency'. Together they form a unique fingerprint.

Cite this